Ocata Therapeutics Inc Stock OTC Bulletin Board

Stocks

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

16-02-10	Ocata Therapeutics : Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries	PR
16-01-22	Ocata Therapeutics : Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics	PR
15-12-28	Ocata Therapeutics : Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem Cells	BU
15-12-03	Ocata Therapeutics : Hemangio-derived Mesenchymal Cells Preserve Kidney Function and Extend Lifespan in Preclinical Model of Lupus Nephritis	BU
15-11-24	Ocata Therapeutics : Harwood Feffer LLP : Announces Investigation of Ocata Therapeutics, Inc.	PR

Manager	Title	Age	Since
John Heffernan PRN	Corporate Officer/Principal	-	2015-02-02

Director	Title	Age	Since
Toru Yoshimitsu BRD	Director/Board Member	63	-
Masaaki Hirano BRD	Director/Board Member	59	-
Percival Barretto-Ko BRD	Director/Board Member	53	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	+1.84%	-0.66%	+59.82%	+94.48%	54.88B
ARGENX SE	+0.55%	-5.54%	+57.57%	+130.84%	54.63B
INSMED INCORPORATED	-2.24%	+3.59%	+17.75%	+469.23%	25.06B
BIONTECH SE	-1.60%	-6.21%	-18.96%	-16.06%	23.14B
WUXI BIOLOGICS (CAYMAN) INC.	-1.69%	-1.27%	+39.51%	-8.30%	19.87B
GENMAB A/S	+0.41%	+2.82%	+36.95%	-27.37%	17.55B
PHARMAESSENTIA CORPORATION	-6.84%	+2.18%	+195.12%	+364.56%	16.5B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-2.42%	-3.72%	+47.02%	+635.77%	15.75B
EXELIXIS, INC.	-1.05%	+1.16%	+25.95%	+191.69%	14.2B
Average	-1.45%	-0.28%	+51.19%	+203.87%	26.84B
Weighted average by Cap.	-0.64%	-1.45%	+50.49%	+173.14%

Employees

Sector